ATE199901T1 - 10,11-dihydro-10-oxo-5h-dibenz(b,f)azepin-5- carboxamidderivate - Google Patents

10,11-dihydro-10-oxo-5h-dibenz(b,f)azepin-5- carboxamidderivate

Info

Publication number
ATE199901T1
ATE199901T1 AT97108465T AT97108465T ATE199901T1 AT E199901 T1 ATE199901 T1 AT E199901T1 AT 97108465 T AT97108465 T AT 97108465T AT 97108465 T AT97108465 T AT 97108465T AT E199901 T1 ATE199901 T1 AT E199901T1
Authority
AT
Austria
Prior art keywords
dibenz
azepine
dihydro
oxo
carboxamide derivatives
Prior art date
Application number
AT97108465T
Other languages
English (en)
Inventor
Jan Benes
Patricio Manue Soares-Da-Silva
David Alexander Learmonth
Original Assignee
Portela & Ca Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Portela & Ca Sa filed Critical Portela & Ca Sa
Application granted granted Critical
Publication of ATE199901T1 publication Critical patent/ATE199901T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • C07D223/30—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hetero atoms directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
AT97108465T 1996-05-27 1997-05-26 10,11-dihydro-10-oxo-5h-dibenz(b,f)azepin-5- carboxamidderivate ATE199901T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PT101876A PT101876B (pt) 1996-05-27 1996-05-27 Novos derivados de 10,11-di-hidro-10-oxo-5h-dibenzo(b,f)azepina-5-carboxamida

Publications (1)

Publication Number Publication Date
ATE199901T1 true ATE199901T1 (de) 2001-04-15

Family

ID=20085604

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97108465T ATE199901T1 (de) 1996-05-27 1997-05-26 10,11-dihydro-10-oxo-5h-dibenz(b,f)azepin-5- carboxamidderivate

Country Status (19)

Country Link
US (1) US5866566A (de)
EP (1) EP0810216B1 (de)
JP (1) JP3592892B2 (de)
CN (1) CN1101382C (de)
AR (1) AR007291A1 (de)
AT (1) ATE199901T1 (de)
AU (1) AU713807B2 (de)
BR (1) BR9703403B1 (de)
CA (1) CA2206172C (de)
DE (1) DE69704297T2 (de)
DK (1) DK0810216T3 (de)
ES (1) ES2156319T3 (de)
GR (1) GR3035910T3 (de)
PL (1) PL189298B1 (de)
PT (1) PT101876B (de)
RU (1) RU2187503C2 (de)
SI (1) SI0810216T1 (de)
TR (1) TR199802462T2 (de)
WO (1) WO1997045416A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004203644B2 (en) * 1999-12-20 2008-04-17 Novartis Ag Pharmaceutical compositions
GB9930058D0 (en) * 1999-12-20 2000-02-09 Novartis Ag Organic compounds
GB0112812D0 (en) * 2001-05-25 2001-07-18 Portela & Ca Sa Mthd for preparation of 10, 11-dihydro-10-hydroxy-5H-dibenz/B,F/azepine-5-c arboxamide and 10,11-dihydro-10-oxo-5H-dibenz/B,F/azepine-5-carb oxamide therefrom

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH500196A (de) * 1969-03-10 1970-12-15 Ciba Geigy Ag Verfahren zur Herstellung von neuen Azepinderivaten
FI75561C (fi) * 1979-10-30 1988-07-11 Ciba Geigy Ag Foerfarande foer framstaellning av 5- karbamoyl-10-oxo-10,11-dihydro-5h-dibens/b,f/azepin och daertill noedvaendiga mellanprodukter.
CH649080A5 (de) * 1981-04-16 1985-04-30 Ciba Geigy Ag 5h-dibenz(b,f)azepin-5-carboxamide als mittel zur prophylaxe und behandlung von zerebraler leistungsinsuffizienz.
US5466683A (en) * 1994-08-25 1995-11-14 Teva Pharmaceutical Industries Ltd. Water-soluble analogs of carbamazepine

Also Published As

Publication number Publication date
GR3035910T3 (en) 2001-08-31
AU2974097A (en) 1998-01-05
SI0810216T1 (de) 2001-08-31
CA2206172C (en) 2002-07-16
BR9703403A (pt) 1998-09-15
CN1226234A (zh) 1999-08-18
ES2156319T3 (es) 2001-06-16
TR199802462T2 (xx) 2000-07-21
AU713807B2 (en) 1999-12-09
AR007291A1 (es) 1999-10-27
PT101876A (pt) 1997-12-31
JP3592892B2 (ja) 2004-11-24
EP0810216B1 (de) 2001-03-21
DE69704297D1 (de) 2001-04-26
DK0810216T3 (da) 2001-07-23
EP0810216A1 (de) 1997-12-03
PL189298B1 (pl) 2005-07-29
JPH1081669A (ja) 1998-03-31
RU2187503C2 (ru) 2002-08-20
MX9703846A (es) 1998-06-30
CN1101382C (zh) 2003-02-12
WO1997045416A1 (en) 1997-12-04
US5866566A (en) 1999-02-02
BR9703403B1 (pt) 2010-06-29
DE69704297T2 (de) 2001-09-20
PL330141A1 (en) 1999-04-26
PT101876B (pt) 1999-09-30
CA2206172A1 (en) 1997-11-27

Similar Documents

Publication Publication Date Title
ATE340176T1 (de) Substituierte 6,5-heterobicyclische-derivate
DK0925298T3 (da) Substituerede 6,6-heterobicykliske derivater
DK1000048T3 (da) Substituerede 1,2,3,4-tetrahydronapthalenderivater
NO2006016I1 (no) 7,8,9,10-tetrahydro-6H-6,10-metanoazepinoÄ4,5-gÜkinoksalintartrat
PT993456E (pt) 4,5-diaril-imidazoles 2-substituidos
PT901474E (pt) Derivados de aril-pirimidina.
NL300150I1 (nl) 4"-Gesubstitueerde 9-deoxo-9A-AZA-9A-homoërythromycine-A-derivaten.
DE69718771D1 (de) Substituierte 1,2,3,4-tetrahydronaphthalinderivate
DK0922050T3 (da) 3-Descladinose-2,3-anhydroerythromycin-derivater
ID21413A (id) Turunan-turunan 1,3,8,-triaza-spiro (4,5) dekan-4-on
TR199800988A3 (tr) 5' Deoksi-Sitidin türevleri.
ATE227282T1 (de) 2,4-diaminopyrimidin-derivate
DE69714358D1 (de) 9,10-disubstituierte campothecinderivate mit antitumoraktivität
ATE199901T1 (de) 10,11-dihydro-10-oxo-5h-dibenz(b,f)azepin-5- carboxamidderivate
TR28915A (tr) Naftokinon türevleri.
DK1068200T3 (da) 2,4,4-trisubstituerede-1,3-dioxolanfungicider
ID24047A (id) Turunan 5-tersubstitusi-3-oksaziazolil 1,6-naftiridin-2 1h-on
DE69722064D1 (de) 1,25-Dihydroxy-16,22,23-trisdehydro-Cholecalciferol-Derivate
BR9510036A (pt) Derivados de 1,3,4-oxadiazina
BR9708948A (pt) 1,3 - Benzodioxois substituídos
TR199700927A3 (tr) N-Benzilazolyum türevleri.
BR1100649A (pt) Derivados de 10,11-metano dibenzo suberano
FI962118A0 (fi) Foerbaettrad anordning foer behandling av roekgaser, saerskilt avgaser
HUP9903001A3 (en) Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee